九福来

Jufeel and J. Streicher enter into agreement on NASDAQ main board sponsorship

Jufeel and J. Streicher enter into agreement on NASDAQ main board sponsorship

  Recently, Kaifeng Jufeel Biological Technology Co., Ltd entered into agreement with J. Streicher via email, which is well renewed with a history of 105 years in America. J. Streicher was officially selected to reverse merge certain NASDAQ listed company for Jufeel for backdoor listing purpose.

  J. Streicher will assign top four accounting firm and experienced law firm to enter Jufeel headquarters to commence the financial audit, legal affairs, business model, and other related listing works. In addition, will assist Jufeel to conduct the reform of shareholding system as required by NASDAQ and SEC prior to listing, listing counseling, and package of financial services implementation plans, to submit officially supplementary document in a timely manner to get listed in NASDAQ main board.

  Mr. Zhang Rongxuan revealed that, J.Streicher will dispatch related management after the signing of preliminary agreement, inclusive of the president of Asian division, president of China division, to the registered place, Henan Province to sign official agreement with Jufeel.

  J. Streicher has a history of 106 year in New York, and it is a diversified financial company. So far, J. Streicher has successfully completed the listing of Disney, KLM Royal Dutch Airlines, Harley Davidson, and Sunoco etc.

  The financial consultant, director of Zhongkerongchuang, Mr. Xue Wentao said, NASDAQ main board is attractive to enterprises world-wide, internet and biological technology, as the two major most popular board, where Apple Incorporated and Microsoft Corporation were born, as well as a list of world-renowned biotechnology enterprises, for instance, Gilead, R&E Biotechnology Corp, Illumina, Vertex and Mylan NV.

  As the research report revealed by Guosen Securities in October 2015, “Rhyme of ice and fire: Game of Technologies-Mystery of strength of NASDAQ biological technology index,” the biological technology industry displayed the most dynamic and promising industry among medical health care general industry, and the total market value of biological technology has accounted for 11.2% of the entire NASDAQ market value, making it the largest industry.

  At the same time, NASDAQ biological technology index shows the characteristics of high returns comparing with other stock indexes. Under the circumstance of decline of NASDAQ by 208%, while biological technology still rose 507% against the trend. From the lowest point of the index during recession in 2008, there is 238% of rise of composite index; however, there is 507% of rise during the same for biological technology index, far beyond the rise of composite index. Since 2010, the biological technology index witnessed a rise of 358%.

Back to list